France-headquartered speciality chemicals Arkema has selected the location of Jurong Island in Singapore to launch its new bio-based polyamide plant.
The company will manufacture the amino 11 monomer and its flagship Rilsan polyamide 11 resins at the plant. Rilsan polyamide 11 is derived from castor oil and as such is the only 100% bio-sourced polyamide approved for many of the most demanding applications, in particular in the electronics, 3D printing, oil and gas extraction, and automotive markets, as a substitute to metal, according to Arkema (@Arkema_group).
Erwoan Pezron, Global Group President for Arkema’s Technical Polymers business line, said: “This major investment bolsters our global presence in bio-sourced materials while bringing us significantly closer to our customers in Asia. Singapore’s industrial and innovation-friendly environment is, we believe, a key asset for our project.”
According to Arkema, Singapore also has “many advantages in terms of infrastructure, logistics, industrial integration and operational excellence, as well as optimisation of the activity’s carbon footprint”.
The project is of the company’s “exceptional investments totalling some €500m earmarked for the 2018-2021 period”.
The company said it expect to complete the plant by late 2021.